Concepedia

Mark Freedman

MF

Statistics

Publications

23

Citations

4.3K

H-Index

19

Active since

1975

Affiliations

Ottawa Hospital(Current)

Icahn School of Medicine at Mount Sinai

Sanofi (France)

University Hospital of Basel

University of Ottawa

Mark Freedman is an author at Ottawa Hospital specializing in multiple sclerosis, neurology, and multiple sclerosis therapy.

Publications per year

1975–2020

23

Publications

23

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Paul O’Connor, Jerry S. Wolinsky, Christian Confavreux et al. · New England Journal of Medicine · 2011 · 976 citations · Full text

, , +15

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

, , +9

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

Christian Confavreux, Paul O’Connor, Mark Freedman et al. · The Lancet Neurology · 2014 · 570 citations

, , +10

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial

Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi et al. · Multiple Sclerosis Journal · 2013 · 351 citations · Full text

, , +16

Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial

Aaron Miller, Jerry S. Wolinsky, Ludwig Kappos et al. · The Lancet Neurology · 2014 · 298 citations

, , +7

1–5 of 23